BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 12488232)

  • 1. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning.
    Jaeschke H
    Am J Physiol Gastrointest Liver Physiol; 2003 Jan; 284(1):G15-26. PubMed ID: 12488232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of hypochlorite-modified proteins by neutrophils during ischemia-reperfusion injury in rat liver: attenuation by ischemic preconditioning.
    Hasegawa T; Malle E; Farhood A; Jaeschke H
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G760-7. PubMed ID: 15994427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic preconditioning in hepatic ischemia and reperfusion.
    Suzuki S; Inaba K; Konno H
    Curr Opin Organ Transplant; 2008 Apr; 13(2):142-7. PubMed ID: 18685294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
    Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
    Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning.
    Teoh N; Leclercq I; Pena AD; Farrell G
    Hepatology; 2003 Jan; 37(1):118-28. PubMed ID: 12500196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning.
    Matsumoto T; O'Malley K; Efron PA; Burger C; McAuliffe PF; Scumpia PO; Uchida T; Tschoeke SK; Fujita S; Moldawer LL; Hemming AW; Foley DP
    Surgery; 2006 Nov; 140(5):793-802. PubMed ID: 17084723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can ischemic preconditioning alone really protect organs from ischemia reperfusion injury in transplantation.
    Huang Y; Shan J; Wang C; Ma J; Li D; Li L; Li S; Li Y
    Transpl Immunol; 2009 Jan; 20(3):127-31. PubMed ID: 18761408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory mediators of liver ischemia-reperfusion injury.
    Walsh KB; Toledo AH; Rivera-Chavez FA; Lopez-Neblina F; Toledo-Pereyra LH
    Exp Clin Transplant; 2009 Jun; 7(2):78-93. PubMed ID: 19715511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischaemic preconditioning in transplantation and major resection of the liver.
    Banga NR; Homer-Vanniasinkam S; Graham A; Al-Mukhtar A; White SA; Prasad KR
    Br J Surg; 2005 May; 92(5):528-38. PubMed ID: 15852422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current progress in the understanding of and therapeutic strategies for ischemia and reperfusion injury of the liver.
    Arii S; Teramoto K; Kawamura T
    J Hepatobiliary Pancreat Surg; 2003; 10(3):189-94. PubMed ID: 14605974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioning effects on expression of proto-oncogenes c-fos and c-jun after hepatic ischemia/reperfusion in rats.
    Xiao JS; Cai FG; Niu Y; Zhang Y; Xu XL; Ye QF
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):197-202. PubMed ID: 15908315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of hepatic ischemia/reperfusion injury and ischemic preconditioning in mice revealed the protective role of ATP5beta.
    Xu C; Zhang X; Yu C; Lu G; Chen S; Xu L; Ding W; Shi Q; Li Y
    Proteomics; 2009 Jan; 9(2):409-19. PubMed ID: 19142948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of reactive oxygen species in mediating hepatic ischemia-reperfusion injury and its therapeutic applications in liver transplantation.
    Zhang W; Wang M; Xie HY; Zhou L; Meng XQ; Shi J; Zheng S
    Transplant Proc; 2007 Jun; 39(5):1332-7. PubMed ID: 17580134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiology of liver ischemia-reperfusion injury].
    Ildefonso JA; Arias-Díaz J
    Cir Esp; 2010 Apr; 87(4):202-9. PubMed ID: 20060518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against lung damage in reduced-size liver transplantation.
    Franco-Gou R; Roselló-Catafau J; Peralta C
    Crit Care Med; 2006 May; 34(5):1506-13. PubMed ID: 16540955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver.
    de Rougemont O; Lehmann K; Clavien PA
    Liver Transpl; 2009 Oct; 15(10):1172-82. PubMed ID: 19790166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia-reperfusion injury of the human liver during hepatic resection.
    Kim YI
    J Hepatobiliary Pancreat Surg; 2003; 10(3):195-9. PubMed ID: 14605975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion.
    Peralta C; Perales JC; Bartrons R; Mitchell C; Gilgenkrantz H; Xaus C; Prats N; Fernández L; Gelpí E; Panés J; Roselló-Catafau J
    Am J Pathol; 2002 Jun; 160(6):2111-22. PubMed ID: 12057915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological preconditioning using intraportal infusion of L-arginine protects against hepatic ischemia reperfusion injury.
    Giovanardi RO; Rhoden EL; Cerski CT; Salvador M; Kalil AN
    J Surg Res; 2009 Aug; 155(2):244-53. PubMed ID: 19540520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic preconditioning attenuates the oxidant-dependent mechanisms of reperfusion cell damage and death in rat liver.
    Cavalieri B; Perrelli MG; Aragno M; Mastrocola R; Corvetti G; Durazzo M; Poli G; Cutrìn JC
    Liver Transpl; 2002 Nov; 8(11):990-9. PubMed ID: 12424711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.